Prolonged neurological disability following OKT3 therapy for acute renal transplant rejection.
Jeffrey
R F
RF
Department of Renal Medicine, St. James's University Hospital, Leeds, England.
Johnson
M H
MH
Bamford
J M
JM
Giles
G R
GR
Brownjohn
A M
AM
Will
E J
EJ
D000208:Acute Disease; D000328:Adult; D006084:Graft Rejection / Q000628:therapy*; D006801:Humans; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000209:etiology*
D016853:Muromonab-CD3